American International Group, Inc. Otonomy, Inc. Transaction History

American International Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$3.7 - $4.75 $66,677 - $85,599	-18,021 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$4.05 - $6.1 $3,928 - $5,917	-970 Reduced 5.11%	18,021 $76,000
Q4 2017 Feb 09, 2018	BUY	$2.8 - $5.55 $249 - $493	89 Added 0.47%	18,991 $105,000
Q3 2017 Nov 09, 2017	BUY	$3.2 - $20.8 $60,486 - $393,161	18,902	18,902 $61,000

Ticker OTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,990,400
Description
Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.